Wirostko Barbara 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Other
Common Stock
2017-12-29$1.01/sh+12,355$12,479→ 240,397 total
Footnotes (1)
- [F1]The shares were acquired under the Issuer's Employee Stock Purchase Plan on December 29, 2017 in a transaction exempt under Rule 16b-3(c).